Eptacog alfa biosimilar (International Biotech Center Generium)

依他凝血素α生物类似药 (International Biotech Center Generium)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEptacog alfa biosimilar (International Biotech Center Generium)

Drug Alias NameCoagyl VII重组凝血因子VIIa生物仿制药 (International Biotech Center Generium)Human blood coagulation factor VII依他凝血素α生物仿制药 (International Biotech Center Generium)GNR-001

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factorBiologics > Biosimilar

Mechanisms of ActionCoagulation factor IX stimulantsCoagulation factor X stimulantsBlood coagulation pathway activation +[4]

TargetsCoagulation factor IXCoagulation factor X

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsHemophilia A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryRussian Federation

Original Approved Date2015/01/01

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesInternational Biotech Center Generium

China Registration ClassN/A

Develop Information

Active CompaniesInternational Biotech Center Generium

Inactive CompaniesN/A

Active IndicationsHemophilia A

Inactive IndicationsN/A

Other Information

ATC CodeB02BD08